You have not verified your Email yet. Please verify your Email to create alerts
Verify EmailLASA
Lasa Supergenerics
|
SMS Lifesciences
|
Gufic Biosciences
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-6.11 % | 11.9 % | 26.14 % |
5yr average Equity Multiplier
|
1.61 | 2.39 | 2.92 |
5yr Average Asset Turnover Ratio
|
0.76 | 1.0 | 1.09 |
5yr Avg Net Profit Margin
|
-5.47 % | 4.92 % | 9.03 % |
Price to Book
|
1.09 | 1.31 | 7.62 |
P/E
|
0.0 | 44.82 | 35.33 |
5yr Avg Cash Conversion Cycle
|
20.11 Days | -18.6 Days | -18.02 Days |
Inventory Days
|
51.19 Days | 79.26 Days | 77.22 Days |
Days Receivable
|
29.63 Days | 40.71 Days | 81.36 Days |
Days Payable
|
82.8 Days | 141.19 Days | 141.41 Days |
5yr Average Interest Coverage Ratio
|
-17.38 | 4.88 | 10.3 |
5yr Avg ROCE
|
1.63 % | 13.21 % | 33.27 % |
5yr Avg Operating Profit Margin
|
11.3 % | 10.6 % | 17.37 % |
5 yr average Debt to Equity
|
0.31 | 0.52 | 0.73 |
5yr CAGR Net Profit
|
26.27 % | -8.48 % | 29.43 % |
5yr Average Return on Assets
|
-3.66 % | 4.94 % | 10.12 % |
Shareholdings
|
|||
Promoter Holding
|
53.65 % | 71.19 % | 72.51 % |
Share Pledged by Promoters
|
20.66 % | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-10.82 % | 2.93 % | 6.76 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -6.16 % |
Lasa Supergenerics
|
SMS Lifesciences
|
Gufic Biosciences
|
|
---|---|---|---|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|